| 产品名称 | BEZ235 |
|---|---|
| 英文名称 | BEZ235 |
| 别名 | NVP-BEZ235, Dactolisib |
| 英文别名 | 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile |
| 规格或纯度 | ≥99% |
| 运输条件 | 超低温冰袋运输 |
| 生化机理 | BEZ235 is a PI 3-kinase (PI3K) tyrosine kinase inhibitor and shows dual PI3K/mTOR inhibition (IC50 = 4, 5, 7 and 75 nM for PI 3-Kα, -γ, -δ, and -β, respectively). BEZ235 showed high target specificity and demonstrated antiproliferative activity against tumor cell lines in animal models of cancer. BEZ235 is an mTOR Complex 1 and mTOR Complex 2 catalytic inhibitor. BEZ235 also inhibits ATR (IC50 = 21nM).Potent, ATP-competitive Phosphatidylinositol 3- kinase\xa0(PI3K) inhibitor (IC 50 = 4, 5, 7 and 75 nM for PI3Kα, -γ, -δ, and -β respectively) and mTOR inhibitor. Able to directly induce G 1 arrest and inhibit angiogenesis in vitro and potentiate the effic |
BEZ235 (NVP-BEZ235, Dactolisib) ATP竞争性的抑制PI3K和mTOR,对p110α/γ/δ/β和mTOR(p70S6K)均有抑制作用,IC50分别为4 nM/5 nM/7 nM/75 nM/6 nM,对ATR也有抑制作用,IC50为21 nM;但对Akt和PDK1抑制作用微弱。A dual PI3K and mTOR inhibitor
BEZ235 (NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively. Inhibits ATR with IC50 of 21 nM, whileshown to be a poor inhibitor to Akt and PDK1.
A dual PI3K and mTOR inhibitor
| CAS编号 | 915019-65-7 |
|---|---|
| 溶解性 | Soluble in chloroform (1 mg/ml), 1-methyl-2-pyrrolidnone (2 mg/mL at 75 °C), DMSO (1.33 mg/mL), and DMF (10 mg/mL at 75 °C). |
| 储存温度 | -20°C储存 |
| 分子量 | 469.54 |
| 分子式 | C30H23N5O |
| 品牌 | 阿拉丁 |
| 备注 | 如果有可能,您尽量在同一天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| PubChem CID | 11977753 |